NTRA logo

NATERA INC

NTRANASDAQ
πŸ† #261 by market capEarnings Nov 5US Equity
$411.15β–Ό $0.62 (βˆ’0.15%)
Live
πŸ””
Track NTRA
Get earnings, price moves & breaking news on Telegram
Track
24hβ–Ό 0.1%
7dβ–² 5.2%
14dβ–² 17.2%
30dβ–² 25.9%
ytdβ–² 79.5%
1yβ–² 152.1%
🏦Market Cap
$58.88B
Mid Cap
πŸ“ˆRevenue Growth (YoY)
+35.9%
High Growth
πŸ“ŠGross Margin
65.3%
High
πŸ’΅FCF Margin
2.6%
Thin
βš–οΈP/S Ratio
21.8x
Expensive
Otter Score
44
Weak

Trading Snapshot

Day Range
$409.54 – $415.78
52-Week Range
$157.43 – $421.64
Volume
$3.19B
Avg Volume
$2.28B
Shares Outstanding
143.2M
Next Earnings
Nov 23, 2026

Fundamentals Snapshot

Annual Revenue
$2.31B
Last Q Revenue
$753M
P/E Ratio
-302.3
P/S Ratio
21.8x
EPS (TTM)
$-1.34
Dividend Yield
0.00%
Dilution (1yr)
+9.6%

Why Investors Own NTRA

  • βœ“High-growth profile β€” revenue up +0.1% YoY with expanding US Equity exposure.
  • βœ“Healthy economics β€” 30% gross margin and 20% free-cash-flow margin.
  • βœ“New products and segments could unlock additional revenue streams.
⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

NTRA logo

NATERA INC

NTRA
Financial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$2.3Bβ–² +35.9% YoY
Gross MarginOf every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
64.8%β–² +7.6% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
βˆ’$310Mβ–² +39.4% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
$109Mβ–² +57.6% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing owner’s slice.
136.7Mβ–² +9.6% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
$862Mβ–² +$103M YoY
StockOtter Β· stockotter.space

About NATERA INC

Natera, Inc. is a diagnostics company focused on developing and commercializing a wide array of molecular testing services globally. Its portfolio includes several key offerings: Panorama, a non-invasive prenatal test (NIPT) that screens for chromosomal abnormalities in a fetus using a blood sample from the mother, and also determines zygosity in twin pregnancies. Vistara, designed to identify single-gene disorders by screening for specific single-gene mutations. Horizon, a comprehensive carrier screening test to determine an individual's carrier status for various genetic diseases. Spectrum, utilized during in vitro fertilization (IVF) cycles to detect chromosomal anomalies or inherited genetic conditions. Anora, a miscarriage analysis product that examines fetal chromosomes to help understand the cause of pregnancy loss. Non-invasive paternity testing, which establishes paternity during gestation using blood samples from both the pregnant mother and the alleged father. Beyond reproductive health, Natera also provides specialized tests: Signatera, a sophisticated circulating tumor DNA (ctDNA) technology capable of screening for a generic set of mutations, independent of the individual's specific tumor characteristics. Prospera, a test used to assess and monitor organ transplant rejection. Additionally, the company offers Constellation, a cloud-based software platform that provides laboratory clients with access to Natera's proprietary algorithms and bioinformatics, enabling them to validate and launch their own tests. Natera distributes its products through a direct sales team and an extensive network of approximately 100 laboratory and distribution partners. The company has strategic partnerships, including one with BGI Genomics Co., Ltd. for the development, manufacturing, and commercialization of NGS-based genetic testing assays, and another with Foundation Medicine, Inc. to develop and commercialize personalized circulating tumor DNA monitoring assays. Founded in 2003, Natera, Inc. is headquartered in Austin, Texas. It was formerly known as Gene Security Network, Inc. before changing its name in 2012.

🦦

Otter Score Breakdown

How it's scoredFive components, each rated 1–5β˜… and equally weighted (20%), averaged to a 0–100 score:πŸ’Ž Quality β€” gross marginπŸš€ Growth β€” revenue YoYβš–οΈ Valuation β€” P/S ratio⚑ Momentum β€” 30-day price changeπŸ’§ Dilution β€” 1-yr share issuance (buybacks score higher)
πŸ’ŽQualityβ˜…β˜…β˜…β˜…β˜…
πŸš€Growthβ˜…β˜…β˜…β˜…β˜…
βš–οΈValuationβ˜…β˜…β˜…β˜…β˜…
⚑Momentumβ˜…β˜…β˜…β˜…β˜…
πŸ’§Dilutionβ˜…β˜…β˜…β˜…β˜…
Overall Score
Weak
44/100

Analyst Price Target

β“˜
Average Target
$537.02
β–² +30.6% Upside
High Target$634.23
Low Target$440.21
Based on 19 analysts

Latest News & Updates